This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1985.
Company Filing History:
1 out of 834,411 Years Active: 1985
Title: Innovations of Alain De Pover in Calcium Channel Blocking Agents
Introduction
Alain De Pover is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmacology, particularly in the development of methods for administering calcium channel blocking agents. His innovative approach has the potential to enhance the effectiveness of existing medications.
Latest Patents
Alain De Pover holds a patent for a method of potentiating the effect of dihydropyridine derivatives, such as nimodipine or nifedipine. This method involves administering d-cis-diltiazem in an amount sufficient to inhibit calcium influx without causing a substantial decrease in contractility. The patent describes a calcium channel blocking composition that comprises a synergistic combination of d-cis-diltiazem and a dihydropyridine derivative. He has 1 patent to his name.
Career Highlights
Throughout his career, Alain De Pover has focused on advancing medical treatments through innovative methodologies. His work has contributed to a better understanding of calcium channel blockers and their applications in clinical settings.
Collaborations
Alain has collaborated with notable professionals in his field, including Arnold Schwartz and Ingrid L Grupp. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Alain De Pover's contributions to the field of pharmacology, particularly through his patent on calcium channel blocking agents, highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the development of effective therapies in this area.